Letter to the Editor: Deliberations More Than a Cut‐off Hepatitis B Surface Antigen Value for Nucleos(t)ide Analogue Cessation
Wen‐Juei Jeng, Yao‐Chun Hsu, Tung‐Hung Su, Chien‐Hung Chen – 22 February 2019
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero, Laura M. Kulik, Claude B. Sirlin, Andrew X. Zhu, Richard S. Finn, Michael M. Abecassis, Lewis R. Roberts, Julie K. Heimbach – 21 February 2019
The Antiresection Activity of the X Protein Encoded by Hepatitis Virus B
Laifeng Ren, Ming Zeng, Zizhi Tang, Mingyuan Li, Xiaojun Wang, Yang Xu, Yuding Weng, Xiaobo Wang, Huan Wang, Liandi Guo, Bing Zuo, Xin Wang, Si Wang, Jiangyan Lou, Yaxiong Tang, Dezhi Mu, Ning Zheng, Xianhui Wu, Junhong Han, Antony M. Carr, Penelope Jeggo, Cong Liu – 21 February 2019 – Chronic infection of hepatitis B virus (HBV) is associated with an increased incidence of hepatocellular carcinoma (HCC).
Phenobarbital‐Induced Liver Injury With Nodal Angiomatosis
Li‐Ting Cheng, Matthew M. Yeh, Chun‐Chi Lu – 21 February 2019
Treatment for Advanced Hepatocellular Carcinoma: Current Standard and the Future
Alisa Likhitsup, Nataliya Razumilava, Neehar D. Parikh – 21 February 2019
The Impact of Translational Research in Hepatology
Johann Felden, Amanda J. Craig, Augusto Villanueva – 21 February 2019
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero, Laura M. Kulik, Claude B. Sirlin, Andrew X. Zhu, Richard S. Finn, Michael M. Abecassis, Lewis R. Roberts, Julie K. Heimbach – 21 February 2019
Treatment for Advanced Hepatocellular Carcinoma: Current Standard and the Future
Alisa Likhitsup, Nataliya Razumilava, Neehar D. Parikh – 21 February 2019
Surveillance and Diagnosis of Hepatocellular Carcinoma
Jane Lim, Amit G. Singal – 21 February 2019